| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | Director | Common Stock | 95,815 | $225,165 | $2.35 | 09 Jan 2026 | Direct |
| Bolt Projects Holdings, Inc. | Director | Common Stock | 72,500 | $24,650 | $0.3400 | 25 Nov 2024 | Direct |
| Golden Arrow Merger Corp. | Director | Class B Common Stock | 0 | 13 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2026 | 1 | $0 | 4 | Director | 13 Jan 2026, 16:06 |
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2025 | 1 | $0 | 4 | Director | 13 Jan 2025, 16:07 |
| BSLK | Bolt Projects Holdings, Inc. | 25 Nov 2024 | 2 | $0 | 4 | Director | 27 Nov 2024, 16:30 |
| BSLK | Bolt Projects Holdings, Inc. | 13 Aug 2024 | 2 | $0 | 4 | Director | 15 Aug 2024, 16:41 |
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2024 | 1 | $0 | 4 | Director | 11 Jan 2024, 16:08 |
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2023 | 1 | $0 | 4 | Director | 11 Jan 2023, 15:18 |
| LSTA | CALADRIUS BIOSCIENCES, INC. | 10 Jan 2022 | 1 | $0 | 4 | Director | 12 Jan 2022, 15:12 |